Adipokines, inflammation, and visceral adiposity across the menopausal transition: A prospective study

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1104-1110

  Lee, Christine G ^a   Carr, Molly C ^a   Murdoch, Susan J ^a   Mitchell, Ellen ^a   Woods, Nancy F ^a   Wener, Mark H ^a   Chandler, Wayne L ^a   Boyko, Edward J ^b   Brunzell, John D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AMYLOID A PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; CLIMACTERIUM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 65249119817     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0701     Document Type: Article

References (36)

1. Kanaley JA, Sames C, Swisher L, Swick AG, Ploutz-Snyder LL, Steppan CM, Sagendorf KS, Feiglin D, Jaynes EB, Meyer RA, Weinstock RS 2001 Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism 50:976-982
2. Tchernof A, Desmeules A, Richard C, Laberge P, Daris M, Mailloux J, Rheaume C, Dupont P 2004 Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 89:3425-3430
3. Gohlke-Barwolf C 2000 Coronary artery disease-is menopause a risk factor? Basic Res Cardiol 95(Suppl 1):I77-183
4. Tilg H, Moschen AR 2006 Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772-783
5. Berg AH, Scherer PE 2005 Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939 -949
6. Gustafson B, Hammarstedt A, Andersson CX, SmithU 2007 Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Ar- terioscler Thromb Vasc Biol 27:2276-2283
7. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Kloting N, Stumvoll M, Bashan N, Rudich A 2007 Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92:2240 -2247
8. He G, Pedersen SB, Bruun JM, Lihn AS, Jensen PF, Richelsen B 2003 Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects. Horm Metab Res 35:178-182
9. Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, Kovacs M, Vargha P, Szekeres O, Speer G, Karadi I, Sikter M, Kaszas E, DworakO, Gero G, Cseh K 2003 Expression of tumor necrosis factor (TNF)-α protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-α, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149:129 -135
10. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM 2007 Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293:E656-E665
11. Yang RZ, Lee MJ, Hu H, PollinTI, RyanAS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW 2006 Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3:e287
12. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S 2007 The correlation between adiposity and adiponectin, tumor necrosis factor a, in- terleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 30:210-214
13. Carr MC 2003 The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404 -2411
14. Pradhan AD, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM, Ridker PM 2004 Tissue plasminogen activator antigen and D- dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 110:292-300
15. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
16. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM 2002 Inflammatory bi- omarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288:980 -987
17. Woods NF, Mitchell ES 1996 Patterns of depressed mood in midlife women; observations from the Seattle Midlife Women's Health Study. Res Nurs Health 19:111-123
18. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG 2004 The meno- pausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 7:375-389
19. Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, LiX, Yosef M, Symons J 2007 Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 92:895-901
20. Chandler WL, Alessi MC, Aillaud MF, Henderson P, Vague P, Juhan-Vague I 1997 Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation 96:761-768
21. Cioffi M, Esposito K, Vietri MT, Gazzerro P, D'Auria A, Ardovino I, Puca GA, Molinari AM 2002 Cytokine pattern in postmenopause. Maturitas 41:187-192
22. Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M 2001 Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 36:547-557
23. Vural P, Akgul C, Canbaz M 2006 Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 54:298 -302
24. Matthews KA, Schott LL, Bromberger J, Cyranowski J, Everson-Rose SA, Sowers MF 2007 Associations between depressive symptoms and inflamma- tory/hemostatic markers in women during the menopausal transition. Psychosom Med 69:124 -130
25. Poitou C, Coussieu C, Rouault C, Coupaye M, Cancello R, Bedel JF, Gouillon M, Bouillot JL, Oppert JM, Basdevant A, Clement K 2006 Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring) 14:309 -318
26. Herder C, Muller-Scholze S, Rating P, Koenig W, Thorand B, Haastert B, Holle R, Illig T, Rathmann W, Seissler J, Wichmann HE, Kolb H2006 Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Eur J Endocrinol 154:311-317
27. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E 2003 Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107:690 -695
28. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA 2004 Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44:1812-1818
29. Sowers MR, Wildman RP, Mancuso P, Eyvazzadeh AD, Karvonen-Gutierrez CA, Rillamas-Sun E, Jannausch ML 2008 Change in adipocytokines and ghrelin with menopause. Maturitas 59:149 -157
30. Wildman RP, Mancuso P, Wang C, Kim M, Scherer PE, Sowers MR 2008 Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations. Int J Obes (Lond) 32:740 -748
31. Dua A, Hennes MI, Hoffmann RG, Maas DL, Krakower GR, Sonnenberg GE, Kissebah AH 1996 Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 45:1635-1637
32. Perrini S, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, Caccioppoli C, Natalicchio A, Orlando MR, Garruti G, De Fazio M, Catalano G, Memeo V, Giorgino R, Giorgino F 2008 Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 51:155-164
33. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE 2003 Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459 -469
34. Cooper GS, Baird DD 1995 The use of questionnaire data to classify peri- and premenopausal status. Epidemiology 6:625-628
35. Žegura B, Gužič-Salobir B, Šebeš tjen M, Keber I 2006 The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fi- brinolysis, lipids, and lipoproteins in healthy postmenopausal women. Menopause 13:643-650
36. Mueck OA, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H 2007 Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause 14:978 -984